Προωθημένο
Innovative Therapies for SSc-ILD and PAH: What Clinicians Should Know
Systemic sclerosis (SSc), also known as scleroderma, is a rare and multifaceted autoimmune disorder defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Once considered a relentlessly progressive disease with limited treatment options, systemic sclerosis is now being transformed by advances in immunomodulation, antifibrotic therapy, and...
0 Σχόλια 0 Μοιράστηκε 80 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο